Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by DermTech, Inc. < Previous 1 2 3 Next > DermTech Files for Voluntary Chapter 11 Protection June 18, 2024 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Reports First-Quarter 2024 Financial Results May 14, 2024 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech to Explore Strategic Alternatives and Implement Restructuring Plan April 18, 2024 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 01, 2024 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology March 08, 2024 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Reports Fourth-Quarter 2023 Financial Results February 29, 2024 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Announces Release Date for Fourth-quarter 2023 Financial Results February 13, 2024 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations January 31, 2024 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types January 18, 2024 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay January 16, 2024 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT) January 08, 2024 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 14, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Reports Third-Quarter 2023 Financial Results November 02, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Announces Release Date for Third-Quarter 2023 Financial Results October 12, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Grants New CCO Mark Aguillard Inducement Award Under NASDAQ Listing Rule 5635(c)(4) September 21, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Announces Contracts With Highmark for the Foundational Assay of Its DermTech Melanoma Test (DMT) September 19, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Appoints Mark Aguillard as Chief Commercial Officer September 11, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 25, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Reports Second-Quarter 2023 Financial Results August 03, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Announces Favorable Coverage Policy With Blues Plan in Michigan for the Foundational Assay of Its DermTech Melanoma Test (DMT) July 19, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Announces Release Date for Second-Quarter 2023 Financial Results July 17, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Adds Approximately 7 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT) July 12, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Announces Restructuring to Prioritize Growth Opportunities and Streamline Operations June 28, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK ECRI Completes Evaluation of the Pigmented Lesion Assay (PLA), the Foundational Assay for the DermTech Melanoma Test (DMT) June 14, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Announces Contract With Hawaii Blues Plan for the Foundational Assay of Its DermTech Melanoma Test (DMT) June 07, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) June 02, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Surpasses 200,000 Cumulative Billable Samples for the DermTech Melanoma Test (DMT) May 31, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Announces Agreements With South Carolina Blues Plan and the United Mine Workers of America Health and Retirement Funds for the Foundational Assay of Its DermTech Melanoma Test (DMT) May 11, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Grants New CEO Bret Christensen Inducement Award Under NASDAQ Listing Rule 5635(c)(4) May 10, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK DermTech Appoints Bret Christensen as New President and CEO May 09, 2023 From DermTech, Inc. Via Business Wire Tickers DMTK < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.